eat . sleep . move . live


Dr. Evan Lewis


Nutarniq Corp is the evolution of Dr. Lewis's research. Learn more today

Research Program

Evan’s interest in human performance research developed from his experiences as an athlete competing on the Canadian Sailing Team. After retiring as a competitive athlete, Evan completed his MSc at the University of Toronto, Faculty of Kinesiology where he investigated the hydration and energy requirements for Canadian Sailing Team athletes in preparation for the 2012 Olympics.  Evan completed his PhD in the Department of Nutritional Sciences, Faculty of Medicine at the University of Toronto where he investigated the effects of omega-3 supplementation on neuromuscular function and adaptations to exercise. His research looks across the health spectrum examining the clinical effects of omega-3 supplementation as a therapeutic intervention for diabetic sensorimotor polyneuropathy alongside the effects on neuromuscular adaptations to training in elite athletes. 


Research Awards

Training 09 Upwind Headshot.JPG

Nutarniq Corp - Targeted nutritional therapy

Nutarniq Corp. develops targeted nutritional therapies for chronic disease complications. Nutarniq’s flagship product, Nutarniq Essentials Diabetic Neuropathy Supplement, is a therapeutic solution for individuals with diabetes and neuropathy. Developed by Nutarniq CEO Dr. Lewis, Nutarniq Essentials is a full spectrum clinical grade omega-3s supplement designed to provide all three essential omega-3s to support nerve structure and function.

Viivio App

A lifestyle app for iWatch and iPhone that provides scientific based recommendations to improve health and reduce chronic disease risk.